Cargando…
Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338993/ https://www.ncbi.nlm.nih.gov/pubmed/37439071 http://dx.doi.org/10.1002/jia2.26093 |
_version_ | 1785071751939489792 |
---|---|
author | Gandhi, Monica Nachega, Jean Miller, Veronica Wilkin, Timothy |
author_facet | Gandhi, Monica Nachega, Jean Miller, Veronica Wilkin, Timothy |
author_sort | Gandhi, Monica |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10338993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103389932023-07-14 Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia Gandhi, Monica Nachega, Jean Miller, Veronica Wilkin, Timothy J Int AIDS Soc Viewpoint John Wiley and Sons Inc. 2023-07-13 /pmc/articles/PMC10338993/ /pubmed/37439071 http://dx.doi.org/10.1002/jia2.26093 Text en © 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Viewpoint Gandhi, Monica Nachega, Jean Miller, Veronica Wilkin, Timothy Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia |
title | Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia |
title_full | Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia |
title_fullStr | Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia |
title_full_unstemmed | Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia |
title_short | Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia |
title_sort | benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with hiv with viremia |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338993/ https://www.ncbi.nlm.nih.gov/pubmed/37439071 http://dx.doi.org/10.1002/jia2.26093 |
work_keys_str_mv | AT gandhimonica benefitsandlimitationsofdifferentstudydesignsforlongactingantiretroviraltherapyamongpeoplelivingwithhivwithviremia AT nachegajean benefitsandlimitationsofdifferentstudydesignsforlongactingantiretroviraltherapyamongpeoplelivingwithhivwithviremia AT millerveronica benefitsandlimitationsofdifferentstudydesignsforlongactingantiretroviraltherapyamongpeoplelivingwithhivwithviremia AT wilkintimothy benefitsandlimitationsofdifferentstudydesignsforlongactingantiretroviraltherapyamongpeoplelivingwithhivwithviremia |